The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification

References

• Haroche J, Cohen-Aubart F, Rollins BJ, et al. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol. 2017;18:e113–e125.
   PubMed Web of Science ®Google Scholar
• Berres ML, Allen CE, Merad M. Pathological consequences of misguided Dendritic Cell differentiation in histiocytic diseases. Adv Immunol. 2013;120:127–161.
   PubMed Web of Science ®Google Scholar
• Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208–209.
   PubMed Web of Science ®Google Scholar
• Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997;29:157–166.
   PubMedGoogle Scholar
• Emile JF, Abla O, Fraitag S, Histiocyte Society, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672–2681.
   PubMed Web of Science ®Google Scholar
• Vital C, Bioulac-Sage P, Tison F, et al. Brain stem infiltration by mixed Langerhans cell histiocytosis and Chester-Erdheim disease: more than just an isolated case? Clin Exp Pathol. 1999;47:71–76.
   PubMedGoogle Scholar
• Hervier B, Haroche J, Arnaud L, et al.; French Histiocytoses Study Group. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood. 2014;124:1119–1126.
   PubMed Web of Science ®Google Scholar
• Minkov M, Picarsic J, Lakatos K. Central nervous system Langerhans cell histiocytosis. In: Abla O, Janka G, editors. Histiocytic disorders. Cham (Switzerland): Springer; 2018. p. 87–101.
   Google Scholar
• Engelbreth-Holm J, Teilum G, Christensen E. Eosinonhilie granuioma of bone or Schiiller-Christian’s disease. Acta Med Scandinav. 1945;118:292–312.
   Google Scholar
• Mirra JM. Histiocytoses (Chapter 14). Philadelphia (PA): Lea & Febiger 1989.
   Google Scholar
• Favara BE, McCarthy RC, Mierau GW. Histiocytosis X. Hum Pathol. 1983;14:663–676.
   PubMed Web of Science ®Google Scholar
• Picarsic J, Jaffe R. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 2015;29:799–823.
   PubMed Web of Science ®Google Scholar
• Haroche J, Arnaud L, Cohen-Aubart F, et al. Erdheim-Chester disease. Curr Rheumatol Rep. 2014;16:412.
   PubMed Web of Science ®Google Scholar
• Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135:1929–1945.
   PubMed Web of Science ®Google Scholar
• Toya T, Ogura M, Toyama K, et al. Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan. Haematologica. 2018;103:1815–1824.
   PubMed Web of Science ®Google Scholar
• Ozkaya N, Rosenblum MK, Durham BH, et al. The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort. Mod Pathol. 2018;31:581–597.
   PubMed Web of Science ®Google Scholar
• Razanamahery J, Diamond EL, Cohen-Aubart F, et al. Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1. Haematologica. 2020;105:e5–e8.
   PubMed Web of Science ®Google Scholar
• Durham BH. Molecular characterization of the histiocytoses: neoplasia of dendritic cells and macrophages. Semin Cell Dev Biol. 2019;86:62–76.
   PubMed Web of Science ®Google Scholar
• Zelger BW, Sidoroff A, Orchard G, et al. Non-Langerhans cell histiocytoses. A new unifying concept. Am J Dermatopathol. 1996;18:490–504.
   PubMed Web of Science ®Google Scholar
• Caputo R, Marzano AV, Passoni E, et al. Unusual variants of non-Langerhans cell histiocytoses. J Am Acad Dermatol. 2007;57:1031–1045.
   PubMed Web of Science ®Google Scholar
• Luder CM, Nordmann TM, Ramelyte E, et al. Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations. J Eur Acad Dermatol Venereol. 2018;32:926–934.
   PubMed Web of Science ®Google Scholar
• Bonometti A, Berti E. Reticulohistiocytoses: a revision of the full spectrum. J Eur Acad Dermatol Venereol. 2020;34:1684–1694.
   PubMed Web of Science ®Google Scholar
• Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131:2877–2890.
   PubMed Web of Science ®Google Scholar
• Berres ML, Lim KP, Peters T, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211:669–683.
   PubMed Web of Science ®Google Scholar
• Ozer E, Sevinc A, Ince D, et al. BRAF V600E mutation: a significant biomarker for prediction of disease relapse in pediatric Langerhans cell histiocytosis. Pediatr Dev Pathol. 2019;22:449–455.
   PubMed Web of Science ®Google Scholar
• Héritier S, Emile JF, Barkaoui MA, et al. BRAF Mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol. 2016;34:3023–3030.
   PubMed Web of Science ®Google Scholar
• Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121:1495–1500.
   PubMed Web of Science ®Google Scholar
• Diamond EL, Durham BH, Ulaner GA, et al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019;567:521–524.
   PubMed Web of Science ®Google Scholar
• Heisig A, Sörensen J, Zimmermann S, et al. Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature. Oncotarget. 2018;9:22236–22240.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al.; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Brower AC, Worsham GF, Dudley AH. Erdheim-Chester disease: a distinct lipoidosis or part of the spectrum of histiocytosis?. Radiology. 1984;151:35–38.
   PubMed Web of Science ®Google Scholar
• Adle-Biassette H, Chetritt J, Bergemer-Fouquet AM, et al. Pathology of the central nervous system in Chester-Erdheim disease: report of three cases. J Neuropathol Exp Neurol. 1997;56:1207–1216.
   PubMed Web of Science ®Google Scholar
• Kambouchner M, Colby TV, Domenge C, et al. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology. 1997;30:353–358.
   PubMed Web of Science ®Google Scholar
• Boralevi F, Léauté-Labrèze C, Tison F, et al. Langerhans-cell histiocytosis and Erdheim-Chester disease: probably not a fortuitous association. Ann Dermatol Venereol. 1998;125:335–338.
   PubMed Web of Science ®Google Scholar
• Popolizio T, De Serio A, Scarabino T, et al. [Erdheim Chester disease: autonomous entity or expression of Langerhans cell histiocytosis? Report of a case]. Radiol Med. 1999;97:422–424.
   PubMedGoogle Scholar
• Rosier RN, Rosenberg AE. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-2000. N Engl J Med. 2000;342:875–883.
   PubMedGoogle Scholar
• Hoeger PH, Diaz C, Malone M, et al. Juvenile xanthogranuloma as a sequel to Langerhans cell histiocytosis: a report of three cases. Clin Exp Dermatol. 2001;26:391–394.
   PubMed Web of Science ®Google Scholar
• Shani-Adir A, Chou P, Morgan E, et al. A child with both Langerhans and non-Langerhans cell histiocytosis. Pediatr Dermatol. 2002;19:419–422.
   PubMed Web of Science ®Google Scholar
• Wang KH, Cheng CJ, Hu CH, et al. Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease. Br J Dermatol. 2002;147:770–774.
   PubMed Web of Science ®Google Scholar
• Bisceglia M, Cammisa M, Suster S, et al. Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin slide seminars. Adv Anat Pathol. 2003;10:160–171.
   PubMed Web of Science ®Google Scholar
• Andrade VP, Nemer CCV, Prezotti ANL, et al. Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate. Virchows Arch. 2004;445:405–409.
   PubMed Web of Science ®Google Scholar
• Patrizi A, Neri I, Bianchi F, et al. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports. Dermatology (Basel). 2004;209:57–61.
   PubMed Web of Science ®Google Scholar
• Perez-Gala S, Torrelo A, Colmenero I, et al. Juvenile multiple xanthogranuloma in a patient with Langerhans cell histiocytosis. Actas Dermosifiliogr. 2006;97:594–598.
   PubMedGoogle Scholar
• Furmanczyk PS, Bruckner JD, Gillespy T III, et al. An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis. Skeletal Radiol. 2007;36:885–889.
   PubMed Web of Science ®Google Scholar
• Kong YY, Kong JC, Shi DR, et al. Cutaneous Rosai-Dorfman disease: a clinical and histopathologic study of 25 cases in China. Am J Surg Pathol. 2007;31:341–350.
   PubMed Web of Science ®Google Scholar
• Sachdev R, Shyama J. Co-existent Langerhans cell histiocytosis and Rosai-Dorfman disease: a diagnostic rarity. Cytopathology. 2008;19:55–58.
   PubMed Web of Science ®Google Scholar
• Granier M, Micheau A, Serre I. A rare cause of cardiac tumour: an Erdheim-Chester disease with cardiac involvement co-existing with an intracerebral Langerhans cell histiocytosis. Eur Heart J. 2008;29:1929.
   PubMed Web of Science ®Google Scholar
• Tran DT, Wolgamot GM, Olerud J, et al. An ‘eruptive’ variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis. J Cutan Pathol. 2008;35:50–54.
   PubMed Web of Science ®Google Scholar
• Kerzl R, Eyerich K, Eberlein B, et al. Parallel occurrence of Erdheim-Chester disease and eosinophilic granuloma in the same patient. J Eur Acad Dermatol Venereol. 2009;23:224–226.
   PubMed Web of Science ®Google Scholar
• Tsai JW, Tsou JH, Hung LY, et al. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis. J Am Acad Dermatol. 2010;63:284–291.
   PubMed Web of Science ®Google Scholar
• Yu H, Kong J, Gu Y, et al. A child with coexistent juvenile xanthogranuloma and Langerhans cell histiocytosis. J Am Acad Dermatol. 2010;62:329–332.
   PubMed Web of Science ®Google Scholar
• Naruse H, Shoda H, Okamoto A, et al. A case of osteoarthropathy due to Erdheim-Chester disease with overlapping Langerhans' cell infiltration. Intern Med. 2010;49:1225–1228.
   PubMed Web of Science ®Google Scholar
• O'Malley DP, Duong A, Barry TS, et al. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases. Mod Pathol. 2010;23:1616–1623.
   PubMed Web of Science ®Google Scholar
• Bains A, Parham DM. Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma: a case and review of recent developments. Pediatr Dev Pathol. 2011;14:480–484.
   PubMed Web of Science ®Google Scholar
• Marchal A, Cuny JF, Montagne K, et al. [Associated Langerhans cell histiocytosis and Erdheim-Chester disease]. Ann Dermatol Venereol. 2011;138:743–747.
   PubMed Web of Science ®Google Scholar
• Pineles SL, Liu GT, Acebes X, et al. Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases. J Neuroophthalmol. 2011;31:217–223.
   PubMed Web of Science ®Google Scholar
• Llamas-Velasco M, Cannata J, Dominguez I, et al. Coexistence of Langerhans cell histiocytosis, Rosai-Dorfman disease and splenic lymphoma with fatal outcome after rapid development of histiocytic sarcoma of the liver. J Cutan Pathol. 2012;39:1125–1130.
   PubMed Web of Science ®Google Scholar
• Strehl JD, Stachel KD, Hartmann A, et al. Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review. Int J Clin Exp Pathol. 2012;5:720–725.
   PubMed Web of Science ®Google Scholar
• Abla O, Halliday W, Laughlin S, et al. Central nervous system juvenile xanthogranuloma after langerhans cell histiocytosis. Pediatr Blood Cancer. 2013;60:342–343.
   PubMedGoogle Scholar
• Caoduro C, Ungureanu CM, Rudenko B, et al. 18F-fluoride PET/CT aspect of an unusual case of Erdheim-Chester disease with histologic features of Langerhans cell histiocytosis. Clin Nucl Med. 2013;38:541–542.
   PubMed Web of Science ®Google Scholar
• Yin J, Zhang F, Zhang H, et al. Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy. Oncologist. 2013;18:19–24.
   PubMed Web of Science ®Google Scholar
• Cohen-Barak E, Rozenman D, Schafer J, et al. An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and review of the literature. Int J Dermatol. 2014;53:558–563.
   PubMed Web of Science ®Google Scholar
• Wei J, Zhang Y, Jin J, et al. Cutaneous Rosai-Dorfman disease accompanied by Langerhans cell hyperplasia responsive to combined treatment. Chin Med J. 2014;127:3200.
   PubMed Web of Science ®Google Scholar
• Johnson WT, Patel P, Hernandez A, et al. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation. J Cutan Pathol. 2016;43:270–275.
   PubMed Web of Science ®Google Scholar
• Litzner BR, Subtil A, Vidal CI. Combined cutaneous Rosai-Dorfman disease and localized cutaneous Langerhans cell histiocytosis within a single subcutaneous nodule. Am J Dermatopathol. 2015;37:936–939.
   PubMed Web of Science ®Google Scholar
• Nabi S, Arshad A, Jain T, et al. A rare case of Erdheim-Chester disease and Langerhans cell histiocytosis overlap syndrome. Case Rep Pathol. 2015;2015:949163.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee M, Shin HJ, et al. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report. Childs Nerv Syst. 2016;32:893–896.
   PubMed Web of Science ®Google Scholar
• Liersch J, Carlson JA, Schaller J. Histopathological and clinical findings in cutaneous manifestation of Erdheim-Chester disease and Langerhans cell histiocytosis overlap syndrome associated with the BRAFV600E mutation. Am J Dermatopathol. 2016;39:493–503.
   Web of Science ®Google Scholar
• Martın JM, Jorda E, Martın-Gorgojo A, Beteta G, et al. Histiocytosis with mixed cell populations. J Cutan Pathol. 2016;43:456–460.
   PubMed Web of Science ®Google Scholar
• Neckman JP, Kim J, Mathur M, et al. Diverse cutaneous manifestations of Erdheim-Chester disease in a woman with a history of Langerhans cell histiocytosis. JAAD Case Rep. 2016;2:128–131.
   PubMedGoogle Scholar
• Parreau S, Haroche J, Pommepuy I, et al. [Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity?] Rev Med Interne. 2017;38:482–487.
   PubMed Web of Science ®Google Scholar
• Perić P, Antić B, Knezević-Usaj S, et al. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis. Vojnosanit Pregl. 2016;73:83–87.
   PubMed Web of Science ®Google Scholar
• Woszczyna-Mleczko K, Kowalik A, Harazin-Lechowska A, Bobkiewicz P, et al. Puzzle histiocytosis (solitary mononuclear xanthogranuloma with LCH component). A case report. Pol J Pathol. 2016;67:415–420.
   PubMed Web of Science ®Google Scholar
• Chen M, Ding C, Lu T, et al. Langerhans cell histiocytosis and Erdheim-Chester disease overlap syndrome with bone marrow involvement and type 2 diabetes mellitus. Ann Hematol. 2018;97:189–192.
   PubMed Web of Science ®Google Scholar
• Efared B, Mazti A, Chaibou B, et al. Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC Clin Pathol. 2017;17:5.
   PubMed Web of Science ®Google Scholar
• Papo M, Diamond EL, Cohen-Aubart F, et al. High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. Blood. 2017;130:1007–1013.
   PubMed Web of Science ®Google Scholar
• Ram R, Marolf MD, Chévez-Barrios P, et al. Juvenile xanthogranuloma in a pediatric patient with Langerhans cell histiocytosis. Ocul Oncol Pathol. 2018;4:141–144.
   PubMed Web of Science ®Google Scholar
• Váradi Z, Bánusz R, Csomor J, et al. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease. Onco Targets Ther. 2017;10:521–526.
   PubMed Web of Science ®Google Scholar
• Bellinato F, Maurelli M, Colato C, et al. BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. Br J Dermatol. 2019;180:933–934.
   PubMed Web of Science ®Google Scholar
• Foss-Skiftesvik J, Scheie D, Klausen C, et al. Rare childhood hybrid histiocytosis of the central nervous system-diagnosed by stereotactic brain biopsy with marked treatment response to clofarabine. Childs Nerv Syst. 2018;34:2321–2324.
   PubMed Web of Science ®Google Scholar
• Hashmi H, Murray D, Greenwell J, et al. A rare case of Erdheim-Chester disease (non-langerhans cell histiocytosis) with concurrent Langerhans cell histiocytosis: a diagnostic and therapeutic challenge. Case Rep Hematol. 2018;2018:7865325.
   PubMed Web of Science ®Google Scholar
• Lee TK, Jung TY, Baek HJ, Kim SK, et al. Disseminated juvenile xanthogranuloma occurring after treatment of Langerhans cell histiocytosis: a case report. Childs Nerv Syst. 2018;34:765–770.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Liu W, et al. Mixed histiocytosis: a case report and published work review. J Dermatol. 2018;45:491–495.
   PubMed Web of Science ®Google Scholar
• Shen WC, Chang Liao NF, Lin TY, et al. Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: a case report. J Cutan Pathol. 2019;46:62–66.
   PubMed Web of Science ®Google Scholar
• Hao X, Feng R, Bi Y, et al. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis. J Neurosurg Pediatr. 2018;23:48–53.
   PubMed Web of Science ®Google Scholar
• Huang HJ, Zhong DR. [Clinicopathological and molecular features of Erdheim-Chester disease accompanied with Langerhans cell histiocytosis]. Zhonghua Bing Li Xue Za Zhi. 2019;48:220–224.
   PubMedGoogle Scholar
• Ishikawa M, Endo Y, Uehara A, et al. Cutaneous adult xanthogranuloma with a small portion of BRAFV600E mutated Langerhans cell histiocytosis populations: a case report and the review of published work. J Dermatol. 2019;46:161–165.
   PubMed Web of Science ®Google Scholar
• Mastropolo R, Close A, Allen SW, et al. BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Adv. 2019;3:1848–1853.
   PubMed Web of Science ®Google Scholar
• Muma S, Brotherton BJ, Halestrap P. Empirical treatment of massive lymphadenopathy in a child with mixed type histiocytosis in Kenya. Lancet. 2020;395:e1.
   PubMed Web of Science ®Google Scholar
• Ocak S, Bayramoglu Z, Tugcu D, et al. Mixed Langerhans cell histiocytosis and Erdheim-Chester disease in a girl: a rare and puzzling diagnosis. J Pediatr Hematol Oncol. 2020.
   PubMed Web of Science ®Google Scholar
• Abla O, Janka G. Histiocytic disorders. Cham (Switzerland): Springer International Publishing AG; 2018.
   Google Scholar
• Jaffe HL. Lipid cholesterol granulomatosis. In: Lea F, editor. Metabolic, degenerative and inflammatory diseases of bone and joints. Philadelphia (PA): Lea and Febiger; 1972. p. 535–541.
   Google Scholar
• Athanasou NA, Barbatis C. Erdheim-Chester disease with epiphyseal and systemic disease. J Clin Pathol. 1993;46:481–482.
   PubMed Web of Science ®Google Scholar
• Waite RJ, Doherty PW, Liepman M, et al. Langerhans cell histiocytosis with the radiographic findings of Erdheim-Chester disease. AJR Am J Roentgenol. 1988;150:869–871.
   PubMed Web of Science ®Google Scholar
• Altman J, Winkelmann RK. Xanthomatous cutaneous lesions of histiocytosis X. Arch Dermatol. 1963;87:164–170.
   PubMedGoogle Scholar
• Chu AC. The confusing state of the histiocytoses. Br J Dermatol. 2000;143:475–476.
   PubMed Web of Science ®Google Scholar
• Durham BH, Roos-Weil D, Baillou C, et al. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. 2017;130:176–180.
   PubMed Web of Science ®Google Scholar
• Milne P, Bigley V, Bacon CM, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017;130:167–175.
   PubMed Web of Science ®Google Scholar
• Lim KPH, Milne P, Poidinger M, et al. Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207+ cells. Blood Adv. 2020;4:87–99.
   PubMed Web of Science ®Google Scholar
• Zinn DJ, Chakraborty R, Allen CE. Langerhans cell histiocytosis: emerging insights and clinical implications. Oncology (Williston Park, N.Y.). 2016;30:122–32.
   PubMed Web of Science ®Google Scholar